| abstract |
The present invention provides novel HIV protease inhibitors of formula I, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection and/or AIDS.n n wherein: nR is a group having the formula:n n R² is an amino acid side chain or -(CH₂) y -X-R 2a ; y is 0, 1 or 2; nand X, R⁰, R³ and Y¹ are as defined in the application. |